Logo image of CD

CHINDATA GROUP HOLDINGS-ADR (CD) Stock Fundamental Analysis

NASDAQ:CD - Nasdaq - US16955F1075 - ADR - Currency: USD

8.45  -0.14 (-1.63%)

After market: 8.56 +0.11 (+1.3%)

Fundamental Rating

4

Taking everything into account, CD scores 4 out of 10 in our fundamental rating. CD was compared to 82 industry peers in the IT Services industry. There are concerns on the financial health of CD while its profitability can be described as average. CD shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

In the past year CD was profitable.
CD had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CD reported negative net income in multiple years.
CD had a positive operating cash flow in 4 of the past 5 years.
CD Yearly Net Income VS EBIT VS OCF VS FCFCD Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 0 1B -1B -2B -3B

1.2 Ratios

Looking at the Return On Assets, with a value of 3.12%, CD is in line with its industry, outperforming 59.30% of the companies in the same industry.
Looking at the Return On Equity, with a value of 7.36%, CD is in line with its industry, outperforming 59.30% of the companies in the same industry.
With a Return On Invested Capital value of 4.63%, CD perfoms like the industry average, outperforming 55.81% of the companies in the same industry.
CD had an Average Return On Invested Capital over the past 3 years of 2.48%. This is significantly below the industry average of 22.23%.
The 3 year average ROIC (2.48%) for CD is below the current ROIC(4.63%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.12%
ROE 7.36%
ROIC 4.63%
ROA(3y)0.92%
ROA(5y)-1.87%
ROE(3y)2.06%
ROE(5y)-3.93%
ROIC(3y)2.48%
ROIC(5y)N/A
CD Yearly ROA, ROE, ROICCD Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 0 5 -5 -10 -15 -20

1.3 Margins

CD has a better Profit Margin (14.84%) than 91.86% of its industry peers.
Looking at the Operating Margin, with a value of 27.33%, CD belongs to the top of the industry, outperforming 97.67% of the companies in the same industry.
CD has a better Gross Margin (41.17%) than 66.28% of its industry peers.
CD's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 27.33%
PM (TTM) 14.84%
GM 41.17%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.47%
GM growth 5YN/A
CD Yearly Profit, Operating, Gross MarginsCD Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 0 -50 -100

2

2. Health

2.1 Basic Checks

CD has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, CD has more shares outstanding
CD has a worse debt/assets ratio than last year.
CD Yearly Shares OutstandingCD Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 100M 200M 300M
CD Yearly Total Debt VS Total AssetsCD Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 5B 10B 15B 20B

2.2 Solvency

CD has an Altman-Z score of 1.49. This is a bad value and indicates that CD is not financially healthy and even has some risk of bankruptcy.
CD has a worse Altman-Z score (1.49) than 61.63% of its industry peers.
CD has a Debt/Equity ratio of 0.92. This is a neutral value indicating CD is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.92, CD is not doing good in the industry: 66.28% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Altman-Z 1.49
ROIC/WACC0.48
WACC9.67%
CD Yearly LT Debt VS Equity VS FCFCD Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 5B 10B

2.3 Liquidity

A Current Ratio of 1.99 indicates that CD should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.99, CD is in the better half of the industry, outperforming 62.79% of the companies in the same industry.
CD has a Quick Ratio of 1.99. This is a normal value and indicates that CD is financially healthy and should not expect problems in meeting its short term obligations.
CD has a Quick ratio of 1.99. This is in the better half of the industry: CD outperforms 63.95% of its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.99
CD Yearly Current Assets VS Current LiabilitesCD Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2B 4B 6B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 116.42% over the past year.
CD shows a strong growth in Revenue. In the last year, the Revenue has grown by 60.59%.
CD shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 74.75% yearly.
EPS 1Y (TTM)116.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%121.87%
Revenue 1Y (TTM)60.59%
Revenue growth 3Y74.75%
Revenue growth 5YN/A
Sales Q2Q%49.68%

3.2 Future

The Earnings Per Share is expected to grow by 19.02% on average over the next years. This is quite good.
Based on estimates for the next years, CD will show a very strong growth in Revenue. The Revenue will grow by 22.00% on average per year.
EPS Next Y0.59%
EPS Next 2Y24.1%
EPS Next 3Y27.24%
EPS Next 5Y19.02%
Revenue Next Year40.45%
Revenue Next 2Y31.47%
Revenue Next 3Y28.29%
Revenue Next 5Y22%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
CD Yearly Revenue VS EstimatesCD Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B
CD Yearly EPS VS EstimatesCD Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

3

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 20.61, CD is valued on the expensive side.
Based on the Price/Earnings ratio, CD is valued a bit cheaper than 66.28% of the companies in the same industry.
CD's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.21.
CD is valuated rather expensively with a Price/Forward Earnings ratio of 18.21.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CD indicates a somewhat cheap valuation: CD is cheaper than 70.93% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.44, CD is valued at the same level.
Industry RankSector Rank
PE 20.61
Fwd PE 18.21
CD Price Earnings VS Forward Price EarningsCD Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CD indicates a somewhat cheap valuation: CD is cheaper than 69.77% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 10.91
CD Per share dataCD EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 3 4

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates CD does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as CD's earnings are expected to grow with 27.24% in the coming years.
PEG (NY)34.73
PEG (5Y)N/A
EPS Next 2Y24.1%
EPS Next 3Y27.24%

0

5. Dividend

5.1 Amount

CD does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CHINDATA GROUP HOLDINGS-ADR

NASDAQ:CD (12/18/2023, 8:00:02 PM)

After market: 8.56 +0.11 (+1.3%)

8.45

-0.14 (-1.63%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)11-20 2023-11-20/bmo
Earnings (Next)03-13 2024-03-13/amc
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap3.10B
Analysts82.86
Price Target11.36 (34.44%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)122.13%
Min EPS beat(2)76.75%
Max EPS beat(2)167.5%
EPS beat(4)4
Avg EPS beat(4)89.95%
Min EPS beat(4)13.15%
Max EPS beat(4)167.5%
EPS beat(8)8
Avg EPS beat(8)192.85%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)5.39%
Min Revenue beat(2)0.5%
Max Revenue beat(2)10.28%
Revenue beat(4)4
Avg Revenue beat(4)6.1%
Min Revenue beat(4)0.5%
Max Revenue beat(4)10.28%
Revenue beat(8)7
Avg Revenue beat(8)3.7%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-4.46%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-24.12%
EPS NY rev (1m)0%
EPS NY rev (3m)54.81%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)98760.2%
Revenue NY rev (1m)-0.08%
Revenue NY rev (3m)-0.05%
Valuation
Industry RankSector Rank
PE 20.61
Fwd PE 18.21
P/S 3.94
P/FCF N/A
P/OCF 10.5
P/B 1.95
P/tB 2.09
EV/EBITDA 10.91
EPS(TTM)0.41
EY4.85%
EPS(NY)0.46
Fwd EY5.49%
FCF(TTM)-1.25
FCFYN/A
OCF(TTM)0.8
OCFY9.52%
SpS2.15
BVpS4.33
TBVpS4.03
PEG (NY)34.73
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.12%
ROE 7.36%
ROCE 6.8%
ROIC 4.63%
ROICexc 5.92%
ROICexgc 6.19%
OM 27.33%
PM (TTM) 14.84%
GM 41.17%
FCFM N/A
ROA(3y)0.92%
ROA(5y)-1.87%
ROE(3y)2.06%
ROE(5y)-3.93%
ROIC(3y)2.48%
ROIC(5y)N/A
ROICexc(3y)3.27%
ROICexc(5y)N/A
ROICexgc(3y)3.49%
ROICexgc(5y)N/A
ROCE(3y)3.73%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y13.47%
GM growth 5YN/A
F-Score5
Asset Turnover0.21
Health
Industry RankSector Rank
Debt/Equity 0.92
Debt/FCF N/A
Debt/EBITDA 3.94
Cap/Depr 480.52%
Cap/Sales 95.88%
Interest Coverage 250
Cash Conversion 79.28%
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 1.99
Altman-Z 1.49
F-Score5
WACC9.67%
ROIC/WACC0.48
Cap/Depr(3y)606.68%
Cap/Depr(5y)737.01%
Cap/Sales(3y)125.95%
Cap/Sales(5y)327.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%121.87%
EPS Next Y0.59%
EPS Next 2Y24.1%
EPS Next 3Y27.24%
EPS Next 5Y19.02%
Revenue 1Y (TTM)60.59%
Revenue growth 3Y74.75%
Revenue growth 5YN/A
Sales Q2Q%49.68%
Revenue Next Year40.45%
Revenue Next 2Y31.47%
Revenue Next 3Y28.29%
Revenue Next 5Y22%
EBIT growth 1Y57.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year152.3%
EBIT Next 3Y56.96%
EBIT Next 5Y40.16%
FCF growth 1Y-46.86%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y150.74%
OCF growth 3Y177.53%
OCF growth 5YN/A